PATENT CLAIM ANALYSIS

Application Number: 15761964
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed are methods for modulating splicing of Ataxin 3 mRNA in an animal with modified oligonucleotides. Such compounds and methods are useful to treat, prevent, or ameliorate spinocerebellar ataxia type 3 (SCA3) in an individual in need thereof.

Claim (Index 23):
The oligomeric compound or modified oligonucleotide of  claim 22 , wherein the chemical bridge is 4\u2032-CH(R)\u2014O-2\u2032 and wherein R is methyl.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15835995', '15835698', '15045999', '14009782', '14168812']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8122501083331052
- 35 USC 102 Novelty (BERT): 0.5632620128469364
- Combined Prediction Score: 0.7873512987844884
- Mean Citation Score: 448.29097
- Max Citation Score: 459.91348
- Similarity Product: 311.790898751626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test